Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration

Rheumatology

Volumn 47, Issue 8, 2008, Pages 1213-1218

  Stone, M A ^a,b,c   Pomeroy, E ^a,b   Keat, A ^d   Sengupta, R ^a   Hickey, S ^a   Dieppe, P ^e   Gooberman Hill, R ^e   Mogg, R ^a,b   Richardson, J ^a   Inman, R D ^c  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

^d NORTHWICK PARK HOSPITAL   (United Kingdom)

^e MRC Health Services Research Collaboration   (United Kingdom)

Author keywords

Ankylosing spondylitis; Disease activity; Flare; Outcome measures

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BACKACHE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FUNCTIONAL DISEASE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADULT; AGED; BACK PAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIODICITY; PILOT PROJECTS; PSYCHOMETRICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 45749129162     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken176     Document Type: Article

References (30)

1. National Institute for Health and Clinical Excellence. Ankylosing spondylitis: Adalimumab, etanercept and infliximab (2nd Appraisal Consultation Document). 09/09/2007. http://www.nice.org.uk/guidance/ index.jsp?action=article&o=35642. (9 September 2007, date last accessed)
2. Brophy S, Calin A. Definition of disease flare in ankylosing spondylitis: The patients' perspective. J Rheumatol 2002;29:954-8.
3. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 1991;34:937-44.
4. FitzGerald JD, Grossman JM. Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients. Lupus 1999;8:638-44.
5. Mirzayan MJ, Schmidt RE, Witte T. Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology 2000;39:1316-9.
6. Ng KP, Manson JJ, Rahman A, Isenberg DA. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis Rheum 2006;55:900-4.
7. Chan RW, Lai FM, Li EK et al. Expression of T-beta type 1 T-helper cell transcription factor, in the urinary sediment of lupus patients predicts disease flare. Rheumatology 2007;46:44-8.
8. Caldwell JR, Furst DE, Smith AL et al. Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized study. J Rheumatol 1998;25:30-5.
9. Wolfe F, Johnston C, Yee B. Preliminary criteria for flare in rheumatoid arthritis. Arthritis Rheum 1997;40(Suppl):S312.
10. Fransen J, Hauselmann H, Michel BA, Caravatti M, Stucki G. Responsiveness of the self-assessed rheumatoid arthritis disease activity index to a flare of disease activity. Arthritis Rheum 2001;44:53-60.
11. Silverfield JC, Kamin M, Wu SC, Rosenthal N. Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: A multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study. Clin Ther 2002;24:282-97.
12. Rosenthal NR, Silverfield JC, Wu SC, Jordan D, Kamin M. Tramadol/ acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population. J Am Geriatr Soc 2004;52:374-80.
13. Majani G, Giardini A, Scotti A. Subjective impact of osteoarthritis flare-ups on patients' quality of life. Health Qual Life Outcomes 2005;3:14.
14. Lewis JD, Aberra FN, Lichtenstein GR, Bilker WB, Brensinger C, Strom BL. Seasonal variation in flares of inflammatory bowel disease. Gastroenterology 2004;126:665-73.
15. Basu S, Alavi A. Defining co-related parameters between 'metabolic' flare and 'clinical', 'biochemical', and 'osteoblastic' flare and establishing guidelines for assessing response to treatment in cancer. Eur J Nucl Med Mol Imaging 2007;34:441-3.
16. Bubley GJ. Is the flare phenomenon clinically significant? Urology 2001;58:5-9.
17. Langan SM, Thomas KS, Williams HC. What is meant by a "flare" in atopic dermatitis? A systematic review and proposal. Arch Dermatol 2006;142:1190-6.
18. Ozgocmen S, Godekmerdan A, Ozkurt-Zengin F. Acute-phase response, clinical measures and disease activity in ankylosing spondylitis. Joint Bone Spine 2007;74:249-53.
19. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
20. Calin A, Garrett S, Whitelock H et al. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
21. Doward LC, Spoorenberg A, Cook SA et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003;62:20-6.
22. Kuritz SJ, Landis JR, Koch GG. A general overview of Mantel-Haenszel methods: Applications and recent developments. Annu Rev Public Health 1988;9:123-60.
23. Carette S, Graham D, Little H, Rubenstein J, Rosen P. The natural disease course of ankylosing spondylitis. Arthritis Rheum 1983;26:186-90.
24. Kennedy LG, Edmunds L, Calin A. The natural history of ankylosing spondylitis. Does it burn out? J Rheumatol 1993;20:688-92.
25. Robertson LP, Davis MJ. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology 2004;43:1565-8.
26. Stone M, Sengupta R, Gordon D, Pomeroy E, Mogg R, Keat A. Longitudinal analyses of disease outcome in ankylosing spondylitis yield insight into the natural history of AS. Ann Rheum Dis 2007;66(Suppl II):410.
27. Gooberman-Hill R, Woolhead G, Mackichan F, Ayis S, Williams S, Dieppe P. Assessing chronic joint pain: Lessons from a focus group study. Arthritis Rheum 2007;57:666-71.
28. Goodacre JA, Mander M, Dick WC. Patients with ankylosing spondylitis show individual patterns of variation in disease activity. Br J Rheumatol 1991;30:336-8.
29. Jimenez-Balderas FJ, Mintz G. Ankylosing spondylitis: Clinical course in women and men. J Rheumatol 1993;20:2069-72.
30. Wanders A, van der Heijde D, Landewe R et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial. Arthritis Rheum 2005;52:1756-65.